HIV Prevention Studies

Our Goal is to Find a Vaccine to Prevent HIV Infections Locally and Globally

Imagine A World Without AIDS

Even though new HIV diagnoses in NYC declined from 2001 to 2014 in all transmission groups, certain groups like men who have sex with men (MSM) and young adults remain disproportionately affected. Black and Latino MSM comprised 70% of new diagnoses among MSM in 2015. Factors contributing to high rates of HIV include poverty, stigma, substance use, and mental health issues.

Woman teaching about HIV

Our goal is to help find a vaccine that prevents HIV infection or delays progression to AIDS after HIV infection. Developing a vaccine will save millions of lives worldwide.

Together with Project ACHIEVE of the New York Blood Center, we conduct clinical research studies in preventive HIV vaccines. We are part of the HIV Vaccine Trials Network (HVTN). HVTN is an international collaboration of over 30 research sites on four continents funded by the National Institutes of Health (NIH).

Current Studies

A safe and effective HIV vaccine offers our best hope for ending the HIV epidemic.
We are currently enrolling volunteers for HIV vaccine studies and are looking for HIV negative men and women who are generally healthy and between the ages of 18 and 50 years. To learn more, fill out our short survey and someone will contact you.

Videos About Prevention Research

The AMP Study: HIV and the Prevention Landscape

Bnabs (Broadly Neutralizing Antibodies)

The Importance of Prevention Research: The AMP Study

Progress Toward an HIV Vaccine

How can you help?

Contact us at HIV_Studies@columbia.edu or call/text 347-770-2201.

Interested in one of our studies? Take our short survey and someone will contact you.